CAT and neoplasm: In terms of anti-recurrence efficacy, in an orthotopic tumor model, PTL@GC reduced the tumor burden to 28.42% of the control group, with enhanced TUNEL apoptosis signals and decreased HIF-1α expression, indicating that the Janus structure effectively alleviates hypoxia and induces tumor cell death through the GOx-CAT cascade [46].